ABL DIAGNOSTICS (EPA:ABLD) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
ABL DIAGNOSTICS

PRESS RELEASE

published on 05/08/2026 at 00:01, 4 months 4 days ago

Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
ABL Diagnostics annonce la mise \u00e0 disposition de son rapport financier annuel 2025, consultable sur son site. Assembl\u00e9e g\u00e9n\u00e9rale pr\u00e9vue le 30 juin 2026 \u00e0 Paris. Pr\u00e9sentation de ses produits et services

Rapport Financier Assembl\u00e9e G\u00e9n\u00e9rale ABL Diagnostics Produits Et Services Biologie Mol\u00e9culaire
BRIEF

published on 02/19/2026 at 08:05, 6 months 21 days ago

ABL Diagnostics annonce l'expiration de son accord non contraignant avec ProPhase Labs

Expansion Internationale Réglementation Du Marché Accord Non Contraignant Diagnostics ABL Laboratoires ProPhase
BRIEF

published on 02/19/2026 at 08:05, 6 months 21 days ago

ABL Diagnostics Reveals Expiry of Non-Binding Agreement with ProPhase Labs

International Expansion Market Regulation Non-binding Agreement ABL Diagnostics ProPhase Labs
PRESS RELEASE

published on 02/19/2026 at 08:00, 6 months 21 days ago

Inside Information / Other news releases
ABL Diagnostics informs the expiration of the non-binding Letter of Intent with ProPhase Labs, Inc. Shares insights on continuing efforts and product offerings

Expansion Letter Of Intent Market Update Molecular Biology ABL Diagnostics
BRIEF

published on 11/14/2025 at 08:05, 9 months 28 days ago

ABL Diagnostics s'associe à Eurobio Scientific pour la distribution exclusive en France

Diagnostic Moléculaire Eurobio Scientifique Diagnostics ABL Gamme De Produits VELA Marché De L'hôpital Public
BRIEF

published on 11/14/2025 at 08:05, 9 months 28 days ago

ABL Diagnostics Partners with Eurobio Scientific for Exclusive Distribution in France

Molecular Diagnostics Eurobio Scientific ABL Diagnostics VELA Product Line Public Hospital Market
PRESS RELEASE

published on 11/14/2025 at 08:00, 9 months 28 days ago

Inside Information / Other news releases
ABL Diagnostics appoints Eurobio Scientific as exclusive distributor for its VELA product line in a targeted segment of the French market. The agreement aims to enhance access to NGS and viral genotyping solutions for healthcare professionals and patients

French Market Eurobio Scientific ABL Diagnostics NGS Exclusive Distributor
BRIEF

published on 07/31/2024 at 22:41, 2 years 1 month ago

Availability of ABL Diagnostics' annual financial report

2023 Annual Financial Report Annual Accounts General Assembly ABL Diagnostics
BRIEF

published on 07/31/2024 at 22:41, 2 years 1 month ago

Mise à disposition du rapport financier annuel d'ABL Diagnostics

2023 Assemblée Générale Rapport Financier Annuel Comptes Annuels ABL Diagnostics
PRESS RELEASE

published on 07/31/2024 at 22:36, 2 years 1 month ago

Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
ABL Diagnostics annonce la mise à disposition de son rapport financier annuel 2023 consultable en ligne. Assemblée générale prévue pour le 20 septembre 2024

Assemblée Générale Rapport Financier Maladies Infectieuses ABL Diagnostics Développement Logiciels

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 18 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 53 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 48 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 28 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 53 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 22 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 38 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 42 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 8 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 37 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE